Showing results (21-30 of 110) with videos related to
Sort By:
Pageof 11
Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|July 21, 2011
Functional vagal paraganglioma: a case report illustrating diagnosis and managementHeidi Hornbeek, N Gopalakrishna Iyer, Diane L Carlson, et al.Thyroid : Official Journal of the American Thyroid Association|November 2, 2023
Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid CancersDavid Toro-Tobon, John C Morris, Crystal Hilger, et al.Endocrine-Related Cancer|August 23, 2008
Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancerMabel Ryder, Ronald A Ghossein, Julio C M Ricarte-Filho, et al.Endocrine-Related Cancer|July 6, 2013
Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cellsMatti L Gild, Iñigo Landa, Mabel Ryder, et al.Melanoma Research|June 17, 2016
A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapyLisa Kottschade, Adam Brys, Tobias Peikert, et al.European Journal of Pharmacology|July 22, 2014
Adenosine A1 receptor antagonist, L-97-1, improves survival and protects the kidney in a rat model of cecal ligation and puncture induced sepsisConstance N Wilson, Constance O Vance, Melissa G Lechner, et al.The Oncologist|June 23, 2025
Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancerAlexis LeVee, Esther Peluso, Melissa G Lechner, et al.Immunological Reviews|January 24, 2026
Sex Matters: Hormonal and Chromosomal Determinants of Autoimmunity and Anti-Cancer Immunity Across the LifespanChristian G Bustillos, Esther M Peluso, Sophia L Cha, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitroTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 31, 2021
Immune checkpoint inhibitor-induced hypophysitis: lessons learnt from a large cancer cohortAnupam Kotwal, Samuel G Rouleau, Surendra Dasari, et al.Pageof 11